Old Web
English
Sign In
Acemap
>
authorDetail
>
Hildemann S
Hildemann S
Ankylosing spondylitis
Rheumatology
Clinical endpoint
BASFI
Physical therapy
1
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice.
2008
Clinical and Experimental Rheumatology
Haibel H
Song Ih
Martin Rudwaleit
J. Listing
Hildemann S
J. Sieper
Show All
Source
Cite
Save
Citations (14)
1